U.S., Dec. 10 -- An application to own the trademark for 'XERVYTEG' has been filed on May. 28, 2025.
Owner(s):
MAAT PHARMA; 70, avenue Tony Garnier, , FRANCE
Goods and/or Services:
For: Pharmaceutical and biopharmaceutical products and preparations for medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction, and for treating cancers and diseases, namely, neurological, psychiatric, gastrointestinal, metabolic, inflammatory, autoimmune, and infectious diseases; Pharmaceuticals for treatment, maintaining and restoring human health in the field of disturbed microbial community, and treatment for dysbiosis, cancers, and diseases, in the nature of neurological, psychiatric, gastrointestinal, metaboli...